Table 2.
Associations between different metabolic indices and incident type 2 diabetes (N = 9564)
| Index | Incident type 2 diabetes HR (95% CI) | |
|---|---|---|
| Women (511 cases) | Men (388 cases) | |
| BMI | ||
| Model 1 | *1.51 (1.39, 1.63) | *1.64 (1.45, 1.86) |
| Model 2 | NA | NA |
| Model 3 | *1.49 (1.38, 1.62) | *1.61 (1.42, 1.82) |
| Model 4 | *1.37 (1.26, 1.49) | *1.45 (1.28, 1.65) |
| Model 5 | *1.27 (1.17, 1.38) | *1.25 (1.09, 1.43) |
| WC | ||
| Model 1 | *1.62 (1.49, 1.77) | *1.44 (1.31, 1.58) |
| Model 2 | *1.39 (1.19, 1.61) | 1.15 (0.94, 1.39) |
| Model 3 | *1.37 (1.18, 1.59) | 1.13 (0.92, 1.38) |
| Model 4 | *1.24 (1.07, 1.45) | 1.04 (0.83, 1.31) |
| Model 5 | 1.04 (0.89, 1.22) | 1.04 (0.82, 1.30) |
| 1/HDLa | ||
| Model 1 | *1.58 (1.44, 1.74) | *1.53 (1.36, 1.73) |
| Model 2 | *1.46 (1.33, 1.61) | *1.42 (1.25, 1.61) |
| Model 3 | *1.46 (1.32, 1.61) | *1.40 (1.24, 1.59) |
| Model 4 | *1.29 (1.14, 1.46) | *1.32 (1.14, 1.52) |
| Model 5 | *1.29 (1.14, 1.47) | *1.41 (1.22, 1.63) |
| TGa | ||
| Model 1 | *1.58 (1.44, 1.74) | *1.44 (1.30, 1.58) |
| Model 2 | *1.45 (1.31, 1.60) | *1.30 (1.18, 1.45) |
| Model 3 | *1.41 (1.28, 1.56) | *1.28 (1.15, 1.42) |
| Model 4 | *1.24 (1.10, 1.39) | 1.12 (0.99, 1.27) |
| Model 5 | 1.07 (0.95, 1.21) | 0.94 (0.83, 1.06) |
| VAIa | ||
| Model 1 | *1.65 (1.51, 1.81) | *1.52 (1.36, 1.69) |
| Model 2 | NA | NA |
| Model 3 | *1.49 (1.35, 1.65) | *1.37 (1.22, 1.53) |
| Model 4 | *1.49 (1.36, 1.65) | *1.37 (1.22, 1.53) |
| Model 5 | *1.29 (1.17, 1.43) | *1.23 (1.09, 1.38) |
| LAPa | ||
| Model 1 | *1.83 (1.65, 2.03) | *1.66 (1.47, 1.87) |
| Model 2 | *1.60 (1.41, 1.82) | *1.47 (1.27, 1.70) |
| Model 3 | *1.55 (1.36, 1.76) | *1.43 (1.24, 1.66) |
| Model 4 | *1.35 (1.16, 1.56) | *1.19 (1.01, 1.42) |
| Model 5 | 1.08 (0.93, 1.26) | 0.96 (0.81, 1.15) |
| TyG | ||
| Model 1 | *2.06 (1.86, 2.29) | *1.74 (1.56, 1.94) |
| Model 2 | *1.88 (1.69, 2.09) | *1.58 (1.41, 1.77) |
| Model 3 | *1.82 (1.64, 2.04) | *1.55 (1.38, 1.75) |
| Model 4b | *1.73 (1.52, 1.98) | *1.43 (1.26, 1.62) |
| Model 5 | NA | NA |
HRs are presented per 1 SD increase in the marker
Model 1, adjusted for age and cohort; model 2, additionally adjusted for BMI; model 3, additionally adjusted for systolic BP, treatment for hypertension, smoking and prevalent CVD; model 4, additionally adjusted for HDL-cholesterol, TG and serum lipid-reducing agents; model 5, additionally adjusted for FPG
aMarker is loge transformed
bp value from the interaction test for the difference in HR between women and men <0.05
*p<0.05, by Cox proportional hazards model
NA, not applicable